262 related articles for article (PubMed ID: 29494603)
1. Lipopolysaccharide-binding protein (LBP) can reverse the amyloid state of fibrin seen or induced in Parkinson's disease.
Pretorius E; Page MJ; Mbotwe S; Kell DB
PLoS One; 2018; 13(3):e0192121. PubMed ID: 29494603
[TBL] [Abstract][Full Text] [Related]
2. Lipopolysaccharide-binding protein (LBP) reverses the amyloid state of fibrin seen in plasma of type 2 diabetics with cardiovascular co-morbidities.
Pretorius E; Mbotwe S; Kell DB
Sci Rep; 2017 Aug; 7(1):9680. PubMed ID: 28851981
[TBL] [Abstract][Full Text] [Related]
3. Correlative Light-Electron Microscopy detects lipopolysaccharide and its association with fibrin fibres in Parkinson's Disease, Alzheimer's Disease and Type 2 Diabetes Mellitus.
de Waal GM; Engelbrecht L; Davis T; de Villiers WJS; Kell DB; Pretorius E
Sci Rep; 2018 Nov; 8(1):16798. PubMed ID: 30429533
[TBL] [Abstract][Full Text] [Related]
4. Acute induction of anomalous and amyloidogenic blood clotting by molecular amplification of highly substoichiometric levels of bacterial lipopolysaccharide.
Pretorius E; Mbotwe S; Bester J; Robinson CJ; Kell DB
J R Soc Interface; 2016 Sep; 13(122):. PubMed ID: 27605168
[TBL] [Abstract][Full Text] [Related]
5. Both lipopolysaccharide and lipoteichoic acids potently induce anomalous fibrin amyloid formation: assessment with novel Amytracker™ stains.
Pretorius E; Page MJ; Hendricks L; Nkosi NB; Benson SR; Kell DB
J R Soc Interface; 2018 Feb; 15(139):. PubMed ID: 29445039
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide-binding protein is bound and internalized by host cells and colocalizes with LPS in the cytoplasm: Implications for a role of LBP in intracellular LPS-signaling.
Kopp F; Kupsch S; Schromm AB
Biochim Biophys Acta; 2016 Apr; 1863(4):660-72. PubMed ID: 26804480
[TBL] [Abstract][Full Text] [Related]
7. Substantial fibrin amyloidogenesis in type 2 diabetes assessed using amyloid-selective fluorescent stains.
Pretorius E; Page MJ; Engelbrecht L; Ellis GC; Kell DB
Cardiovasc Diabetol; 2017 Nov; 16(1):141. PubMed ID: 29096623
[TBL] [Abstract][Full Text] [Related]
8. The Potential of LPS-Binding Protein to Reverse Amyloid Formation in Plasma Fibrin of Individuals With Alzheimer-Type Dementia.
Pretorius E; Bester J; Page MJ; Kell DB
Front Aging Neurosci; 2018; 10():257. PubMed ID: 30186156
[TBL] [Abstract][Full Text] [Related]
9. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease.
Forsyth CB; Shannon KM; Kordower JH; Voigt RM; Shaikh M; Jaglin JA; Estes JD; Dodiya HB; Keshavarzian A
PLoS One; 2011; 6(12):e28032. PubMed ID: 22145021
[TBL] [Abstract][Full Text] [Related]
10. Design and Synthesis of Lipopolysaccharide-Binding Antimicrobial Peptides Based on Truncated Rabbit and Human CAP18 Peptides and Evaluation of Their Action Mechanism.
Madanchi H; Ebrahimi Kiasari R; Seyed Mousavi SJ; Johari B; Shabani AA; Sardari S
Probiotics Antimicrob Proteins; 2020 Dec; 12(4):1582-1593. PubMed ID: 32445120
[TBL] [Abstract][Full Text] [Related]
11. Plasma Lipopolysaccharide-Binding Protein Reflects Risk and Progression of Parkinson's Disease.
Chen SJ; Chi YC; Ho CH; Yang WS; Lin CH
J Parkinsons Dis; 2021; 11(3):1129-1139. PubMed ID: 33720853
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide (LPS)-binding protein stimulates CD14-dependent Toll-like receptor 4 internalization and LPS-induced TBK1-IKKϵ-IRF3 axis activation.
Tsukamoto H; Takeuchi S; Kubota K; Kobayashi Y; Kozakai S; Ukai I; Shichiku A; Okubo M; Numasaki M; Kanemitsu Y; Matsumoto Y; Nochi T; Watanabe K; Aso H; Tomioka Y
J Biol Chem; 2018 Jun; 293(26):10186-10201. PubMed ID: 29760187
[TBL] [Abstract][Full Text] [Related]
13. High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes.
Zweigner J; Gramm HJ; Singer OC; Wegscheider K; Schumann RR
Blood; 2001 Dec; 98(13):3800-8. PubMed ID: 11739189
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effect of recombinant bovine wild and mutant lipopolysaccharide-binding protein in lipopolysaccharide-challenged bovine mammary epithelial cells.
Li X; Li L; Sun Y; Wu J; Wang G
Cell Stress Chaperones; 2016 May; 21(3):439-52. PubMed ID: 26813383
[TBL] [Abstract][Full Text] [Related]
15. The role of lipopolysaccharide-binding protein in modulating the innate immune response.
Zweigner J; Schumann RR; Weber JR
Microbes Infect; 2006 Mar; 8(3):946-52. PubMed ID: 16483818
[TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide-binding protein modulates acetaminophen-induced liver injury in mice.
Su GL; Gong KQ; Fan MH; Kelley WM; Hsieh J; Sun JM; Hemmila MR; Arbabi S; Remick DG; Wang SC
Hepatology; 2005 Jan; 41(1):187-95. PubMed ID: 15619225
[TBL] [Abstract][Full Text] [Related]
17. Heparin binds to lipopolysaccharide (LPS)-binding protein, facilitates the transfer of LPS to CD14, and enhances LPS-induced activation of peripheral blood monocytes.
Heinzelmann M; Bosshart H
J Immunol; 2005 Feb; 174(4):2280-7. PubMed ID: 15699163
[TBL] [Abstract][Full Text] [Related]
18. Glucose phosphorylated on carbon 6 suppresses lipopolysaccharide binding to lipopolysaccharide-binding protein and inhibits its bioactivities.
Fujita Y; Yagi K
Int Immunopharmacol; 2017 Apr; 45():43-52. PubMed ID: 28187312
[TBL] [Abstract][Full Text] [Related]
19. Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes. Competition for binding to lipopolysaccharide.
Dentener MA; Von Asmuth EJ; Francot GJ; Marra MN; Buurman WA
J Immunol; 1993 Oct; 151(8):4258-65. PubMed ID: 8409400
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages.
Wright SD; Tobias PS; Ulevitch RJ; Ramos RA
J Exp Med; 1989 Oct; 170(4):1231-41. PubMed ID: 2477488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
